Crossref
26-A-17997-ACC IMPACT OF HORMONE REPLACEMENT THERAPY ON CARDIOVASCULAR EVENT RISK IN POSTMENOPAUSAL WOMEN WITH ATRIAL FIBRILLATION
JACC · 2026-04 · 87 (13) · A72-A73
DOI: 10.1016/j.jacc.2026.02.182 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Emma Lunn und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lunn, E., McGarvey, C., DeMers, L., Feng, H., Marrouche, N. F., & Pandey, A. C. (2026). 26-A-17997-ACC IMPACT OF HORMONE REPLACEMENT THERAPY ON CARDIOVASCULAR EVENT RISK IN POSTMENOPAUSAL WOMEN WITH ATRIAL FIBRILLATION. JACC, 87(13), A72-A73. https://doi.org/10.1016/j.jacc.2026.02.182
Vancouver
Lunn E, McGarvey C, DeMers L, Feng H, Marrouche NF, Pandey AC. 26-A-17997-ACC IMPACT OF HORMONE REPLACEMENT THERAPY ON CARDIOVASCULAR EVENT RISK IN POSTMENOPAUSAL WOMEN WITH ATRIAL FIBRILLATION. JACC. 2026;87(13):A72-A73. doi:10.1016/j.jacc.2026.02.182
BibTeX
@article{Lunn2026,
author = {Lunn, Emma and McGarvey, Cecile and DeMers, Laura and Feng, Han and Marrouche, Nassir F. and Pandey, Amitabh C.},
title = {26-A-17997-ACC IMPACT OF HORMONE REPLACEMENT THERAPY ON CARDIOVASCULAR EVENT RISK IN POSTMENOPAUSAL WOMEN WITH ATRIAL FIBRILLATION},
journal = {JACC},
year = {2026},
volume = {87},
number = {13},
pages = {A72--A73},
doi = {10.1016/j.jacc.2026.02.182}
}
EUVIMED